Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration

Administration of high doses of methamphetamine (METH) causes persistent dopaminergic deficits in both nonhuman preclinical models and METH-dependent persons. Noteworthy, adolescent (i.e., postnatal day (PND) 40) rats are less susceptible to this damage than young adult (PND90) rats. In addition, bi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: McFadden, Lisa M, Hoonakker, Amanda J, Vieira-Brock, Paula L, Stout, Kristen A, Sawada, Nicole M, Ellis, Jonathan D, Allen, Scott C, Walters, Elliot T, Nielsen, Shannon M, Gibb, James W, Alburges, Mario E, Wilkins, Diana G, Hanson, Glen R, Fleckenstein, Annette E
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908924/
https://ncbi.nlm.nih.gov/pubmed/21190217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/syn.20902
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki